Natus Medical Inc
NTUS
NTUS was delisted on the 20th of July, 2022.
1 hedge funds and large institutions have $6K invested in Natus Medical Inc in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 182 closing their positions.
99% less funds holding
Funds holding: 186 → 1 (-185)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $1.05B → $6K (-$1.05B)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 182
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$207M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$103M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$61.7M |
| 4 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$51.6M |
| 5 |
State Street
Boston,
Massachusetts
|
-$45.1M |
NTUS Hedge Fund Activity: Q3 2022 in Review
1 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Natus Medical Inc (NTUS) for Q3 2022, worth a combined $6K — down 100% from $1.05B a quarter earlier.
Sellers outnumbered buyers: 182 funds closed out of NTUS and 0 opened new positions — a net loss of 182 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was BlackRock, exiting entirely with an estimated $207M sold.
- 1 institutional investor held Natus Medical Inc (NTUS) as of Q3 2022, down from 186 in Q2 2022.
- Funds reported $6K of Natus Medical Inc stock for Q3 2022, down 100% quarter-over-quarter.
- 0 funds opened new Natus Medical Inc positions in Q3 2022 and 182 closed out, a net change of -182 holders.
- The largest Natus Medical Inc seller in Q3 2022 was BlackRock, an estimated $207M sold.
Based on aggregated 13F filings for Q3 2022.